New research from Rush University Medical Center suggests that depression is a risk factor for Alzheimer’s disease, not an early result of it.An examination of more than 600 participants in the Chicago Health and Aging Project found little change in symptoms of depression in the six to seven years before Alzheimer’s was diagnosed and no change in depression three years after diagnosis.The …
A molecule implicated in Alzheimer’s disease interferes with brain cells by making them unable to “recycle” the surface receptors that respond to incoming signals, researchers at UT Southwestern Medical Center have found.
( Intermountain Medical Center ) New findings by researchers from the Heart Institute at Intermountain Medical Center in Murray, Utah, reveals treatment of the most common heart rhythm disorder that affects more than two million Americans significantly reduces the risk of stroke, mortality, Alzheimer’s disease and other forms of dementia.
( Boston University Medical Center ) Researchers from Boston University School of Medicine have shown that patients with Alzheimer’s disease (AD) are better able to remember new verbal information when it is provided in the context of music even when compared to healthy, older adults. The findings, which currently appear on-line in Neuropsychologia, offer possible applications in treating and …
An investigational intervention using naturally ocurring antibodies in human blood has preserved the thinking abilities of a group of mild- to moderate-stage Alzheimer’s patients over 18 months and significantly reduced the rate of atrophy (shrinkage) of their brains, according to a study performed at the NewYork-Presbyterian Hospital/Weill Cornell Medical Center.
Donations Help Provide Hands-On Services & Education. Contribute Now.
April 12 (Bloomberg) — More than 2,000 Manhattan residents age 65 and older have given researchers one more reason to tell us to eat more greens. These foods may protect blood vessels in the brain, preventing tiny strokes that may contribute to Alzheimer s , said Nikolaos Scarmeas , an associate professor of neurology at Columbia University Medical Center in New York and author of this study.
No differences in decline among African American and white patientsPeople with Alzheimer’s disease experience a rate of cognitive decline four times greater than those with no cognitive impairment according to a new study by researchers at Rush University Medical Center in Chicago.
( Rush University Medical Center ) People with Alzheimer’s disease experience a rate of cognitive decline four times greater than those with no cognitive impairment according to a new study by researchers at Rush University Medical Center in Chicago.
( American Academy of Neurology ) Memory and thinking skills may decline rapidly for people who have mild cognitive impairment, which is the stage before Alzheimer’s disease when people have mild memory problems but no dementia symptoms, and even more rapidly when dementia begins, which is when Alzheimer’s disease is usually diagnosed. The research is published in the March 23, 2010, print issue …
Rush University Medical Center is leading a nationwide clinical trial of a nutritional drink to determine whether it can improve cognitive performance in people with mild to moderate Alzheimer’s.
Rush University Medical Center is leading a nationwide clinical trial of a nutritional drink to determine whether it can improve cognitive performance in people with mild to moderate Alzheimer’s. The study follows recently released results from an earlier trial conducted in Europe showing that the drink, called Souvenaid, improved verbal recall in people with mild disease who were followed for …
MENLO PARK, Calif.—-Geron Corporation today announced that it has entered into a collaboration jointly funded by Geron and a University of California Discovery Research and Training Grant to investigate the therapeutic potential of its human embryonic stem cell -based product, GRNOPC1, for Alzheimer’s disease.
Rush University Medical Center is leading a nationwide clinical trial of a nutritional drink to determine whether it can improve cognitive performance in people with mild to moderate Alzheimer’s.The study follows recently released results from an earlier trial conducted in Europe showing that the drink, called Souvenaid, improved verbal recall in people with mild disease who were followed for …
Rush University Medical Center is leading a nationwide clinical trial of a nutritional drink to determine whether it can improve cognitive performance in people with mild to moderate Alzheimer’s.
CLEVELAND — University Hospitals Case Medical Center is one of 12 sites conducting the first Phase 2 clinical trial of a gene therapy for Alzheimer’s disease (AD).
University Hospitals Case Medical Center is one of 12 sites conducting the first Phase 2 clinical trial of a gene therapy for Alzheimer’s disease (AD).
( St. Joseph’s Hospital and Medical Center ) Researchers from the Barrow Neurological Institute and aging Hispanic alumni from Phoenix Union High School are partnering in a major research trial to study Alzheimer’s disease in the ethnic community.
Banner Boswell Medical Center invites the community to a free seminar on Alzheimer’s disease from 1 to 3 p.m.
Alzheimer’s patient James McClenton wandered out a medical center in Orange for an hour before he was found by his daughter and police, according to today’s Jersey Journal.